Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 02, 2023
Source ID
10.1080/21645515.2023.2204787

Entities

People

  • Astrid Borkowski
  • Eduardo López-medina
  • Frank Baehner
  • James Sherwood
  • Paul M. Mendelman
  • Pio López
  • Rodrigo Deantonio
  • Taisei Masuda
  • Xavier Sáez-llorens

Tags

Technology Areas

  • Biotechnology